Skip to Main Content

Author Details

Bastien Gerby
Universite de Toulouse, Inserm, Universite Toulouse III-Paul Sabatier
2005
25
14
Sami Nourreddine (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37930337Stem cell-like reprogramming is required for leukemia-initiating activity in B-ALL.J Exp Med2024
34638130The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11.Blood Adv2022
35401501Monoallelic <i>Heb/Tcf12</i> Deletion Reduces the Requirement for NOTCH1 Hyperactivation in T-Cell Acute Lymphoblastic Leukemia.Front Immunol2022
33036026Germline PAX5 mutation predisposes to familial B-cell precursor acute lymphoblastic leukemia.Blood2021
34771671Oncogene-Induced Reprogramming in Acute Lymphoblastic Leukemia: Towards Targeted Therapy of Leukemia-Initiating Cells.Cancers (Basel)2021
32379874A targetable cue in T-cell malignancy.Blood2020
30257940PAX5-ELN oncoprotein promotes multistep B-cell acute lymphoblastic leukemia in mice.Proc Natl Acad Sci U S A2018
30214688<i>PAX5A</i> and <i>PAX5B</i> isoforms are both efficient to drive B cell differentiation.Oncotarget2018
27797342High-throughput screening in niche-based assay identifies compounds to target preleukemic stem cells.J Clin Invest2016
24778454Interleukin-18 produced by bone marrow-derived stromal cells supports T-cell acute leukaemia progression.EMBO Mol Med2014
25522233SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.PLoS Genet2014
23836559Genetic interaction between Kit and Scl.Blood2013
24764466Modelling acute leukemias in mice: clonal evolution and the emergence of leukemic stem cells.BMC Proc2013
22863010Identification of regulators of polyploidization presents therapeutic targets for treatment of AMKL.Cell2012
23045605Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models.J Exp Med2012
21464223Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse.J Exp Med2011
21566655Expression of CD34 and CD7 on human T-cell acute lymphoblastic leukemia discriminates functionally heterogeneous cell populations.Leukemia2011
21382322[How a suppressor of tumor gets hooked of the leukaemic proliferation in man].Med Sci (Paris)2011
19924146Optimized gene transfer into human primary leukemic T cell with NOD-SCID/leukemia-initiating cell activity.Leukemia2010
20682982Iodination increases the activity of verapamil derivatives in reversing PGP multidrug resistance.Anticancer Res2010
20855495NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia.J Exp Med2010
18984862NOTCH is a key regulator of human T-cell acute leukemia initiating cell activity.Blood2009
18984291[Demonstration of leukemic stem cells in the human T-ALLs and study of the involvement of the NOTCH, TAL1 and ERK/MAPK pathways in human T-leukemogenesis].Ann Pathol2008
170492352-Arylidenedihydroindole-3-ones: design, synthesis, and biological activity on bladder carcinoma cell lines.Bioorg Med Chem Lett2007
16279786Piperazinobenzopyranones and phenalkylaminobenzopyranones: potent inhibitors of breast cancer resistance protein (ABCG2).J Med Chem2005
  • 1 - 25 of 25

Recommended Authors

University of Colorado Anschutz Medical Campus
Career Start Year 2009
Number of shared co-authors 0
Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 0
INSERM U1170, Universite Paris Saclay
Career Start Year 2007
Number of shared co-authors 4
University of Toronto
Career Start Year 2006
Number of shared co-authors 0
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2006
Number of shared co-authors 1
NYU Robert I. Grossman School of Medicine
Career Start Year 2006
Number of shared co-authors 0
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2004
Number of shared co-authors 1
Graduate School of Medicine, The University of Tokyo
Career Start Year 2004
Number of shared co-authors 0
Emory University School of Medicine
Career Start Year 2003
Number of shared co-authors 1
University of Parma
Career Start Year 2003
Number of shared co-authors 4
University of California los angeles
Career Start Year 2003
Number of shared co-authors 0
Oregon Health & Science University School of Medicine
Career Start Year 2002
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 2002
Number of shared co-authors 0
Stanford University School of Medicine
Career Start Year 1998
Number of shared co-authors 0
Washington University School of Medicine in St. Louis
Career Start Year 1998
Number of shared co-authors 0
University of Cambridge
Career Start Year 1996
Number of shared co-authors 5
St Jude Children's Research Hospital
Career Start Year 1996
Number of shared co-authors 4
Dana-Farber Cancer Institute
Career Start Year 1995
Number of shared co-authors 8
Mayo Clinic
Career Start Year 1995
Number of shared co-authors 0
University Children's Hospital Muenster
Career Start Year 1994
Number of shared co-authors 0
Hannover Medical School
Career Start Year 1993
Number of shared co-authors 2
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Career Start Year 1992
Number of shared co-authors 2
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Career Start Year 1992
Number of shared co-authors 1
Institute for Life and Medical Sciences, Kyoto University
Career Start Year 1991
Number of shared co-authors 0
Boston Children's Hospital
Career Start Year 1990
Number of shared co-authors 5
St. Jude Children's Research Hospital
Career Start Year 1989
Number of shared co-authors 0
The University of Tokyo.
Career Start Year 1984
Number of shared co-authors 2
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1980
Number of shared co-authors 3
Dana-Farber Cancer Institute
Career Start Year 1975
Number of shared co-authors 4
Sapienza University.
Career Start Year 1968
Number of shared co-authors 3

Collaborators

Department of Biomedical Science and Center for Bio-Nanomaterials, Daegu University
Co-authored papers 6
Universite de Montreal, Institute for Research in Immunology and Cancer
Co-authored papers 4
Universite de Montreal
Co-authored papers 3
University of Campinas (UNICAMP)
Co-authored papers 3
Universite de Montreal
Co-authored papers 2
University of Paris
Co-authored papers 2
Universite de Montreal, Institute for Research in Immunology and Cancer
Co-authored papers 2
Institut de Recherche Saint-Louis, Universite de Paris
Co-authored papers 2
Saint-Louis Hospital
Co-authored papers 2
Broad Institute
Co-authored papers 1
Co-authored papers 1
University of Montreal
Co-authored papers 1
Dana-Farber Cancer Institute
Co-authored papers 1
Walter and Eliza Hall Institute of Medical Research
Co-authored papers 1
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Lille University Hospital, INSERM UMR-S7, CNRS UMR9020, Lille University.
Co-authored papers 1
Broad Institute of MIT and Harvard
Co-authored papers 1
Institute for Research in Immunology and Cancer (IRIC)
Co-authored papers 1
Co-authored papers 1
Leslie Dan Faculty of Pharmacy and Department of Biochemistry, University of Toronto
Co-authored papers 1
Co-authored papers 1
University of California San Diego
Co-authored papers 1
Co-authored papers 1
Universite de Montreal
Co-authored papers 1
McGill University
Co-authored papers 1
Centre hospitalier universitaire de l'Universite de Montreal (CHUM)
Co-authored papers 1
Institute for Research in Immunology and Cancer
Co-authored papers 1
IRIC - University of Montreal
Co-authored papers 1